# DOW Inc.: overview

DOW · NYSE · CIK 1751788 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dow.md) · [Financials](/companies/dow/financials.md) · [Filings](/companies/dow/filings.md) · [Insiders](/companies/dow/insiders.md)

Latest reported revenue: [$11.27bn](/filings/0001751788-26-000160.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:Revenues, accession 0001751788-26-000160).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.9](/filings/0001751788-25-000156.md) | [10.4 d](/filings/0001751788-26-000018.md) | [10.4](/filings/0001751788-26-000134.md) | [10.1](/filings/0001751788-25-000145.md) | [10.0](/filings/0001751788-26-000160.md) | [9.5 d](/filings/0001751788-26-000018.md) | [9.8](/filings/0001751788-26-000134.md) | [11.3](/filings/0001751788-26-000160.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [2.0%](/filings/0001751788-25-000156.md) | [0.3% d](/filings/0001751788-26-000018.md) | [(2.9%)](/filings/0001751788-26-000134.md) | [(8.3%)](/filings/0001751788-25-000145.md) | [0.6%](/filings/0001751788-26-000160.md) | [(14.4%) d](/filings/0001751788-26-000018.md) | [(5.4%)](/filings/0001751788-26-000134.md) | [4.1%](/filings/0001751788-26-000160.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001751788-25-000156.md) | not reported | [(0.44)](/filings/0001751788-26-000134.md) | [(1.18)](/filings/0001751788-25-000145.md) | [0.08](/filings/0001751788-26-000160.md) | not reported | [(0.74)](/filings/0001751788-26-000134.md) | [0.62](/filings/0001751788-26-000160.md) |
| Free cash flow | $bn | [0.1 d](/filings/0001751788-25-000156.md) | [0.0 d](/filings/0001751788-26-000018.md) | [(0.6)](/filings/0001751788-26-000134.md) | [(1.1) d](/filings/0001751788-25-000145.md) | [0.6 d](/filings/0001751788-26-000160.md) | [(0.3) d](/filings/0001751788-26-000018.md) | [0.6](/filings/0001751788-26-000134.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [55.0](/filings/0001751788-24-000010.md) | [56.9](/filings/0001751788-25-000012.md) | [44.6](/filings/0001751788-26-000018.md) | [43.0](/filings/0001751788-26-000018.md) | [40.0](/filings/0001751788-26-000018.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [11.7%](/filings/0001751788-24-000010.md) | [8.2%](/filings/0001751788-25-000012.md) | [1.5%](/filings/0001751788-26-000018.md) | [2.8%](/filings/0001751788-26-000018.md) | [(6.1%)](/filings/0001751788-26-000018.md) |
| Diluted EPS | $ per share | [8.38](/filings/0001751788-24-000010.md) | [6.28](/filings/0001751788-25-000012.md) | [0.82](/filings/0001751788-26-000018.md) | [1.57](/filings/0001751788-26-000018.md) | [(3.70)](/filings/0001751788-26-000018.md) |
| Free cash flow | $bn | [5.5](/filings/0001751788-24-000010.md) | [5.7](/filings/0001751788-25-000012.md) | [2.8](/filings/0001751788-26-000018.md) | [(0.0)](/filings/0001751788-26-000018.md) | [(1.4)](/filings/0001751788-26-000018.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dow/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.69bn | 61,742,580 |  | Added +8,405,052 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.29bn | 47,031,008 |  | Added +837,193 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.04bn | 37,869,410 |  | Added +2,756,021 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $954.5m | 34,887,097 |  | Added +2,051,568 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $525.4m | 19,281,367 |  | Added +503,058 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $489.0m | 17,873,366 |  | Added +13,367,989 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $430.8m | 15,744,500 |  | Added +8,641,482 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $429.5m | 15,698,239 |  | Added +5,381,487 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $413.1m | 15,099,766 |  | Added +1,123,029 |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $342.2m | 12,507,011 |  | Reduced −6,440,591 |

## Recent filings

[All 660 filings](/companies/dow/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 11:44 ET | [10-Q](/filings/0001751788-26-000160.md) | Quarterly report, period 2026-09-30 | 0001751788-26-000160 |
| 2026-10-22 | 10:57 ET | [8-K](/filings/0001751788-26-000155.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001751788-26-000155 |
| 2026-07-24 | 11:41 ET | [10-Q](/filings/0001751788-26-000147.md) | Quarterly report, period 2026-06-30 | 0001751788-26-000147 |
| 2026-07-23 | 10:59 ET | [8-K](/filings/0001751788-26-000144.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001751788-26-000144 |
| 2026-07-10 | 20:19 ET | [8-K](/filings/0001193125-26-300937.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-300937 |
| 2026-07-06 | 20:15 ET | [8-K/A](/filings/0001193125-26-296205.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-296205 |
| 2026-04-24 | 11:30 ET | [10-Q](/filings/0001751788-26-000134.md) | Quarterly report, period 2026-03-31 | 0001751788-26-000134 |
| 2026-04-23 | 10:58 ET | [8-K](/filings/0001751788-26-000131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001751788-26-000131 |
| 2026-04-14 | 10:35 ET | [8-K](/filings/0001193125-26-153769.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-153769 |
| 2026-02-27 | 21:08 ET | [DEF 14A](/filings/0001193125-26-082583.md) | Proxy statement, period 2026-04-09 | 0001193125-26-082583 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001751788-26-000018.md), filed Feb 3, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1751788
- Tickers: DOW
- Exchange: NYSE
- SIC code: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.